Randomized phase III trial of tamoxifen versus thalidomide...

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

Jean A. Hurteau, Mark F. Brady, Kathleen M. Darcy, William P. McGuire, Pamela Edmonds, Michael L. Pearl, Iouri Ivanov, Krishnansu S. Tewari, Robert S. Mannel, Kristine Zanotti, Doris M. Benbrook
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
119
Year:
2010
Language:
english
Pages:
7
DOI:
10.1016/j.ygyno.2010.08.002
File:
PDF, 490 KB
english, 2010
Conversion to is in progress
Conversion to is failed